Steroid hormones are produced by the porcine uterus. We hypothesized that the uterus in pigs possesses active 3β-hydroxysteroid dehydrogenase/Δ(5)-Δ(4) isomerase (3β-HSD) responsible for progesterone and androstenedione production, that uterine steroids may supplement the amount of steroid hormones produced by embryos and corpus luteum and that these steroids are necessary for maintenance of pregnancy. In this study, we examined 1) endometrial and myometrial expression of 3β-HSD mRNA, 2) uterine 3β-HSD protein activity and 3) in vitro production of A(4) and P(4) by uterine slices harvested from pigs on days 10 to 11, 12 to 13 and 15 to 16 of pregnancy and the estrous cycle. The expression of 3β-HSD and the presence and activity of 3β-HSD protein were different in the endometrium and the myometrium during the examined periods of pregnancy and the estrous cycle. Production of A(4) by the endometrium and myometrium was highest on days 12 to 13 of pregnancy and the estrous cycle. Endometrial secretion of P(4) did not differ in the course of early pregnancy and on the respective days of the estrous cycle. The gravid myometrium was the highest source of P(4) in pregnant pigs on days 12 to 13. The release of P(4) by the cyclic myometrium rose during the examined days of the estrous cycle. The steroidogenic activity of the uterus, as described in this study, may support early pregnancy or the luteal phase of the estrous cycle in pigs.
Steroid hormones are produced by the porcine uterus. We hypothesized that the uterus in pigs possesses active 3β-hydroxysteroid dehydrogenase/Δ(5)-Δ(4) isomerase (3β-HSD) responsible for progesterone and androstenedione production, that uterine steroids may supplement the amount of steroid hormones produced by embryos and corpus luteum and that these steroids are necessary for maintenance of pregnancy. In this study, we examined 1) endometrial and myometrial expression of 3β-HSD mRNA, 2) uterine 3β-HSD protein activity and 3) in vitro production of A(4) and P(4) by uterine slices harvested from pigs on days 10 to 11, 12 to 13 and 15 to 16 of pregnancy and the estrous cycle. The expression of 3β-HSD and the presence and activity of 3β-HSD protein were different in the endometrium and the myometrium during the examined periods of pregnancy and the estrous cycle. Production of A(4) by the endometrium and myometrium was highest on days 12 to 13 of pregnancy and the estrous cycle. Endometrial secretion of P(4) did not differ in the course of early pregnancy and on the respective days of the estrous cycle. The gravid myometrium was the highest source of P(4) in pregnant pigs on days 12 to 13. The release of P(4) by the cyclic myometrium rose during the examined days of the estrous cycle. The steroidogenic activity of the uterus, as described in this study, may support early pregnancy or the luteal phase of the estrous cycle in pigs.
Steroid hormones act as potent regulators of cyclic changes within the female reproductive
system as well as in processes that lead to establishment and maintenance of pregnancy. The
patterns of their episodic release are conserved across species with respect to the
preovulatory rise in estrogens followed by progesterone (P4) secretion during the
luteal phase [1, 2]. Most active steroids are derived from the gonads, adrenal glands and placenta
[3]. It has been reported, however, that many other
tissues, including nervous [4] and cardiac tissue [5], can synthesize active steroids that act locally in an
autocrine and paracrine manner.Our recent study conducted on a pig model showed that the uterus is a steroidogenic organ
that produces androgens and estrogens de novo in both early pregnant and
cyclic females [6,7,8]. We have concluded that uterine
production of estrogens may supplement the amount of steroid hormones produced by porcine
embryos and that uterine steroids may provide, as hypothesized, an alternative signal for
pregnancy recognition and maintenance and initiation of implantation [6].Synthesis of steroids in any tissue requires availability of substrates and activity of
enzymes of two major classes–P450 heme-containing proteins and hydroxysteroid dehydrogenases,
with 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) among the
most important [9]. 3β-HSD catalyzes 3β-hydroxysteroid
dehydrogenation and Δ5 to Δ4 isomerization of pregnenolone (PREG),
17α-hydroxypregnenolone, dehydroepiandrosterone (DHEA) and androstenediol
into progesterone, 17α-hydroxyprogesterone, androstenedione (A4)
and testosterone (T), respectively [10]. The presence
of 3β-HSD has been reported in the human and murine placenta, skin, breast tissue, adrenal
gland, liver, ovary and testis [2, 9, 10]. However, although the
inherence of a different dehydrogenase, namely, 15-hydroxyprostaglandin dehydrogenase, in
porcine uterine tissues was recently reported [11],
there is still a lack of evidence related to the presence of active 3β-HSD in these
tissues.It was determined that A4 is a principal circulating androgen in gilts [12]. Past studies showed that the porcine pregnant
endometrium produced higher amounts of A4in vitro than T in
response to exogenous P4 [7]. In cyclic pigs
around the time of luteolysis, the myometrium contributed mostly to the total secretion of
A4 [7]. In response to P4, the
porcine endometrium produced higher amounts of A4 compared with estrone
(E1) or T on days 14 to 16 of pregnancy [7], and P4 is essential for maintenance of pregnancy in this species [13]. Thus, the presence of 3β-HSD, one of the most
important enzymes of steroidogenesis responsible for P4 and A4
synthesis, may be crucial for the control of steroid hormones production in the uterus.Our working hypothesis was that the presence and activity of 3β-HSD in the endometrium and
myometrium creates the potential for synthesis of A4 and P4 in the
uterus. We hypothesized that both uterine tissues produce A4 and P4
mainly during early pregnancy in pigs. To prove our hypothesis, we examined the activity of
3β-HSD and in vitro production of A4 and P4 using a
model of uterine slices harvested from pregnant pigs on days 10 to 11, 12 to 13 and 15 to 16
of pregnancy. The activity of 3β-HSD and the level of A4 and P4 release
in vitro determined in gravid pigs were compared with the levels observed
in cyclic females at the respective days of the estrous cycle. The selected days of pregnancy
in pigs, i.e., days 10 to 11, 12 to 13 and 15 to 16, are important for 1) migration of the
embryos to and within the uterus, 2) maternal recognition of pregnancy and 3) corpus luteum
(CL) protection against luteolysis and the onset of implantation, respectively. At
approximately day 12 of pregnancy, pigs conceptuses initiate the process of attachment to the
uterine luminal surface followed by a rapid morphological rearrangement of the trophoblast
[14]. On days 15 to 16 of pregnancy, luteolysis is
avoided, and the CL is protected to serve as an important source of P4. Thus, days
10 to 16 of pregnancy in pigs coincide with continued antiluteolysis and implantation, which
are critical for the success of pregnancy [15].In particular, the aim of the current study was to investigate if 1) the 3β-HSD gene and
protein are present and active in the porcine endometrium and myometrium harvested during days
10 to 11, 12 to 13 and 15 to 16 of pregnancy and the estrous cycle; 2) endometrial and
myometrial A4 and P4 secretion in vitro differs in the
course of early pregnancy and the estrous cycle; and 3) A4 and P4
release from the uterus in vitro depends on the type of uterine tissue.
Materials and Methods
Animals and collection of endometrial and myometrial tissue for in vitro
incubation
All experiments were approved by the Animal Ethics Committee, University of Warmia and
Mazury in Olsztyn, Poland. Postpubertal pigs weighing 90–110 kg were used on days 10 to 11
(n=4), 12 to 13 (n=4) and 15 to 16 (n=4) of early pregnancy or days 10 to 11 (n=4), 12 to
13 (n=4) and 15 to 16 (n=4) of the estrous cycle. Gilts were observed for estrus behavior
in the presence of an intact boar. The onset of the second estrus was designated as day 0
of the estrous cycle. Gilts assigned to the early pregnancy group were naturally bred on
the second day of estrus. Pregnancy in mated gilts was confirmed by the presence of
embryos after flushing each uterine horn with 20 ml of sterile saline. The stage of the
estrous cycle was also confirmed by morphological changes of the ovaries and CL quality
[16]. After slaughter, uteri were excised, placed
in ice-cold sterile PBS supplemented with 100 IU/ml penicillin (Polfa, Tarchomin, Poland)
and 100 μg/ml streptomycin (Polfa) and transported to the laboratory on ice within 30
min.
Determination of 3βHSD mRNA expression in porcine uterine tissues
Total RNA was extracted from slices of endometrium and myometrium (n=4 for each examined
period) weighing 30 mg using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to
the manufacturer's protocol. To obtain maximum purity of the RNA sample, DNAse (RNase-Free
DNAse Kit, Qiagen) treatment was performed. RNA quality and quantity were determined with
spectrophotometry (NanoDrop ND-1000, Thermo Scientific, Wilmington, DE, USA). Total RNA
samples were transcribed to cDNA using an Omniscript RT Kit (Qiagen) and a mix of dNTPs
and random hexamers as primers. Real-time PCR was performed in duplicate for each sample
using a 7300 Real-Time PCR System and SYBR® Green PCR Master Mix (both Life
Technologies, Grand Island, NY, USA). The conditions of thermal cycling were: initial
denaturation for 10 min at 95 C, denaturation for 15 sec at 95 C, primer annealing for 1
min at 61 C and elongation for 1 min at 72 C followed by dissociation. Specific primers
for hydroxy-delta-5-steroid dehydrogenase were designed with the Primer Express 3.0
software (Life Technologies) and their specificities were confirmed by comparison of their
sequences with the sequence of HSD3B1 deposited in a database and
calculation of the statistical significance of the match using the Basic Local Alignment
Search Tool (BLAST). Levels of gene expression were calculated using the ΔΔCt method and
normalized using the geometrical means of reference gene expression levels: glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and β-actin (ACTB).
The primer sequences are shown in Table
1. Non-template controls were used to confirm amplification specificity for
each set of primers (Table 1).
Table 1.
Used primers sequences
Gene symbol
Primers sequences
Target sequence accession number
Reference
HSD3B1
F: 5'- AGGTTCGCCCGCTCATC-3'
NM_001004049.1
R: 5'- CTGGGCACCGAGAAATACTTG-3'
GAPDH
F: 5'- CCTTCATTGACCTCCACTACATGGT-3'
NM_001206359.1
Bogacka et al. 2006 [17]
R: 5'- CCACAACATACGTAGCACCACGAT -3'
ACTB
F: 5'- GGAGATCGTGCGGGACATCAAG-3'
AJ312193
Staszkiewicz et al. 2007 [18]
R: 5'- GGCGTAGAGGTCCTTCCTGATG-3'
Sequence analysis
The putative HSD3B1 amplicon was isolated from 2.0% agarose gel
(GenElute™ Gel Extraction Kit, Sigma, St. Louis, MO, USA), and the
specificity of the product was confirmed by automated sequencing on an Applied Biosystems
3730xl DNA Analyzer (Life Technologies).
3β-HSD histochemical study
Parts of uterine wall cross-sections containing both endometrium and myometrium were
dissected, frozen in liquid nitrogen and stored in –80 C until determination of 3β-HSD
expression. A day before histochemical staining, uterine tissues were brought to –20 C,
incubated for 12 h and then cut at –20 C in a cryostat (Leica, Wetzlar, Germany) into
7-µm-thick slices. Slides were stored at –20 C. Before histochemical reaction, slides were
brought to room temperature and then incubated for 3 h with pregnenolone (Sigma) or
dehydroepiandrosterone (Sigma) which were use as substrates for 3β-HSD, nitrotetrazolium
blue chloride (Sigma) and nicotinamide adenine dinucleotide (Sigma), which revealed the
protein as blue granules under an optical microscope. After incubation, the slides were
washed in PBS for 5 min and fixed in 4% formalin mix in 0.1 M PBS for 10 min.
Subsequently, they were washed in PBS and redistilled water and then dehydrated. After
dehydration, preparations were mounted with DPX (Sigma) and examined under a light
microscope (Olympus, Tokyo, Japan). The activity of the enzyme expressed as the area of
histochemical reaction was estimated by measuring the number of blue-colorized pixels in
the field of vision and compared with the number of non-colorized pixels using the Cell^F
software (Olympus). The colorized pixels were subtracted by applying a color mask with the
specified intensity threshold (the same for each photograph) to the images. The
specificity of histochemical staining was tested by incubation of cross-sections in the
medium without substrates for 3β-HSD (negative controls).
In vitro incubation of endometrial and myometrial slices
Uterine horns were cut longitudinally, and the endometrium was separated by careful
scraping using a scissors. The myometrium was obtained by tearing it off with tweezers.
Tissues were cut into small pieces and washed twice with sterile PBS. Individual
endometrial and myometrial slices (200–210 mg weight, 3 mm thick) were placed separately
in culture vials containing 2 ml of Medium 199 (Sigma) supplemented with 0.1% BSA fraction
V (Roth, Karlsruhe, Germany), 20 μg nystatin (Sigma) and 20 μg gentamicin (Krka, Novo
Mesto, Slovenia) and then preincubated in vitro in an atmosphere of 95%
O2 and 5% CO2 at 37 C for 18 h. After preincubation, the culture
medium was replaced with fresh medium, and the slices were incubated in
vitro for the next 12 h. After incubation, the culture media were collected and
frozen at –20 C until the concentrations of A4 and P4 were
determined with radioimmunoassay.
Androstenedione (A4) and progesterone (P4)
determination
Concentrations of A4 and P4 were determined by radioimmunoassay
according to the method described by Ciereszko [19]. Cross-reactivity of antisera against A4 and P4 has been
reported by Szafranska et al. [20]. For the A4 assay, the extraction efficiency was 85.8 ± 0.7%,
sensitivity of the assay was 1 pg/ml and the standard curve range was from 1 pg/ml to 500
pg/ml. The intra- and interassay coefficients of variation were 1.2% and 11.6%,
respectively. For the P4 assay, the efficiency of extraction was 85.1 ± 0.3%,
sensitivity of the assay was 2 pg/ml and the standard curve range was from 1 pg/ml to 1000
pg/ml. The intra- and interassay coefficients of variation were 0.8% and 3.7%,
respectively.
Statistical analysis
All data were expressed as the mean ± SEM. The measured areas of histochemical reaction
of 3β-HSD and HSD3B1 mRNA expression were compared between different days
within one examined period with one-way ANOVA followed by the Fisher's LSD post hoc test.
Comparisons between certain days of pregnancy and the estrous cycle were examined with the
Student's t-test. Concentrations of A4 and P4
produced by endometrial and myometrial slices incubated in vitro were
log-transformed and analyzed with the Student's t-test.
Results
HSD3B1 mRNA expression in porcine uterine tissues
Both endometrial and myometrial expression of HSD3B1 mRNA did not change
during the examined days of early pregnancy. The relative transcript abundance in the
pregnant endometrium and myometrium harvested on days 15 to 16 was higher (P<0.05) than
in tissues harvested from cyclic pigs. During the course of the estrous cycle, the
expression level of HSD3B1 in the endometrium was the highest on days 10
to 11 and decreased on days 12 to 13 and days 15 to 16 (P<0.05). The myometrial
expression of HSD3B1 mRNA was highest on days 12 to 13 of the estrous
cycle (P<0.05) (Fig. 1).
Fig. 1.
The relative expression of the HSD3B1 gene in the endometrium and
myometrium harvested from pigs during days 10 to 11, 12 to 13 and 15 to 16 of
pregnancy (n=4 in each period) and the estrous cycle (n=4 in each period). The
expression levels were normalized with the geometric mean expression of reference
genes – GAPDH and ACTB. Data are expressed as the
mean ± SEM. Different small letters (a, b, c) indicate statistical differences in
HSD3B1 expression in tissues within one examined reproductive
state (pregnancy or the estrous cycle; P<0.05). An asterisk (*) indicates
statistical differences in HSD3B1 expression in the same tissues
during corresponding days of pregnancy and the estrous cycle (* 0.01≤P≤0.05).
The relative expression of the HSD3B1 gene in the endometrium and
myometrium harvested from pigs during days 10 to 11, 12 to 13 and 15 to 16 of
pregnancy (n=4 in each period) and the estrous cycle (n=4 in each period). The
expression levels were normalized with the geometric mean expression of reference
genes – GAPDH and ACTB. Data are expressed as the
mean ± SEM. Different small letters (a, b, c) indicate statistical differences in
HSD3B1 expression in tissues within one examined reproductive
state (pregnancy or the estrous cycle; P<0.05). An asterisk (*) indicates
statistical differences in HSD3B1 expression in the same tissues
during corresponding days of pregnancy and the estrous cycle (* 0.01≤P≤0.05).
Activity and localization of 3β-hydroxysteroid
dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) conversion of
dehydroepiandrosterone into androstenedione
Conversion of DHEA into androstenedione by 3β-HSD was present and active in the porcine
uterus harvested during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy and the estrous
cycle. The active enzyme was revealed in stromal, glandular and luminal epithelial cells
of the endometrium and in myocytes (Fig. 2). The activity of 3β-HSD in conversion of DHEA into androstenedione did not differ
in the endometrium harvested from pigs during days 10 to 11 and 12 to 13 of pregnancy
(P>0.05) but was statistically higher than in tissues collected on days 15 to 16
(P<0.05) (Fig. 3). During the estrous cycle, the endometrial 3β-HSD activity was higher on days 10
to 11 and decreased on days 12 to 13 (P<0.05) and days 15 to 16 (P<0.05). The
myometrial activity of 3β-HSD did not differ on days 10 to 11 and 12 to 13 (P>0.05) and
decreased on days 15 to 16 during both pregnancy and the estrous cycle (P<0.05,
respectively). The enzyme activity in tissues incubated without a substrate was
undetectable (Fig. 2).
Fig. 2.
The localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of DHEA into androstenedione in the porcine
endometrium and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of
pregnancy and the estrous cycle. Exemplary areas of enzyme activity are marked with
arrows. GE – glandular epithelium, VE – vascular epithelium, ST – stromal cells, LE
– luminal epithelium, M – myometrium, NC – negative control.
Fig. 3.
The activity of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of DHEA into androstenedione in the porcine
endometrium and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of
pregnancy and the estrous cycle (n=4 in each period). Values are expressed as the
mean ± SEM. Different small letters (a, b, c) indicate significant differences in
3β-HSD activity between different days within one examined period (P<0.05).
Asterisks (***) indicate statistically significant differences in 3β-HSD activity
between the same days of different periods (*** P≤0.001).
The localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of DHEA into androstenedione in the porcine
endometrium and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of
pregnancy and the estrous cycle. Exemplary areas of enzyme activity are marked with
arrows. GE – glandular epithelium, VE – vascular epithelium, ST – stromal cells, LE
– luminal epithelium, M – myometrium, NC – negative control.The activity of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of DHEA into androstenedione in the porcine
endometrium and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of
pregnancy and the estrous cycle (n=4 in each period). Values are expressed as the
mean ± SEM. Different small letters (a, b, c) indicate significant differences in
3β-HSD activity between different days within one examined period (P<0.05).
Asterisks (***) indicate statistically significant differences in 3β-HSD activity
between the same days of different periods (*** P≤0.001).
Activity and localization of 3β-hydroxysteroid
dehydrogenase/Δ5-Δ4 isomerase (3β-HSD) conversion of pregnenolone
into progesterone
Conversion of PREG into P4 by 3β-HSD was present and active in the porcine
uterus harvested during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy and the estrous
cycle. Enzyme activity was visualized in stromal, glandular and luminal epithelial cells
as well as in myocytes (Fig. 4). Endometrial activity of 3β-HSD did not differ during days 10 to 11 and 12 to 13
and decreased on days 15 to 16 of pregnancy (Fig.
5). During the estrous cycle, the highest activity of 3β-HSD was observed in the
endometrium obtained on days 10 to 11 (P<0.05), the activity was decreased on days 12
to 13 and 15 to 16. In tissues harvested on days 12 to 13 and 15 to 16 of the estrous
cycle, the activity of the enzyme did not differ (P>0.05). The quantity of active
3β-HSD was higher in the pregnant endometrium than in the cyclic endometrium only on days
12 to 13 (P<0.05). The pregnant myometrium was the highest source of active 3β-HSD on
days 12 to 13 when compared with the other examined days of pregnancy (P<0.05). During
the estrous cycle, the enzyme activity was lower on days 15 to 16 than on days 10 to 11
and 12 to 13 (P<0.05). On days 10 to 11 of pregnancy, the myometrium expressed lower
amounts of 3β-HSD than cyclic tissue harvested on days 10 to 11 of the estrous cycle
(P<0.05). On days 12 to 13 of pregnancy, the myometrium expressed higher amounts of
active 3β-HSD when compared with the myometrium harvested on days 12 to 13 of the estrous
cycle (P<0.05). The enzyme activity in tissues incubated without a substrate was
undetectable (Fig. 4).
Fig. 4.
The localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of PREG into progesterone in the porcine endometrium
and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
and the estrous cycle. Exemplary areas of enzyme activity are marked with arrows. GE
– glandular epithelium, VE – vascular epithelium, ST – stromal cells, LE – luminal
epithelium, M – myometrium, NC – negative control.
Fig. 5.
The activity of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of PREG into progesterone in the porcine endometrium
and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
and the estrous cycle (n=4 in each period). Values are expressed as the mean ± SEM.
Different small letters (a, b) indicate significant differences in 3β-HSD activity
between different days within the same examined period (P<0.05). Asterisks (*,
**) indicate statistically significant differences in 3β-HSD activity between the
same days of different periods (* 0.01≤P≤0.05, ** 0.001
The localization of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of PREG into progesterone in the porcine endometrium
and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
and the estrous cycle. Exemplary areas of enzyme activity are marked with arrows. GE
– glandular epithelium, VE – vascular epithelium, ST – stromal cells, LE – luminal
epithelium, M – myometrium, NC – negative control.The activity of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4
isomerase (3β-HSD) conversion of PREG into progesterone in the porcine endometrium
and myometrium collected during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
and the estrous cycle (n=4 in each period). Values are expressed as the mean ± SEM.
Different small letters (a, b) indicate significant differences in 3β-HSD activity
between different days within the same examined period (P<0.05). Asterisks (*,
**) indicate statistically significant differences in 3β-HSD activity between the
same days of different periods (* 0.01≤P≤0.05, ** 0.001
Endometrial and myometrial in vitro release of A4
Release of A4 from the endometrium and the myometrium incubated in
vitro was statistically higher during days 12 to 13 of both pregnancy and the
estrous cycle than during other days of the examined periods (P<0.05) (Fig. 6). Endometrial and myometrial release of A4 on days 10 to 11 did not
differ from the release on days 15 to 16 in both pregnant and cyclic tissues (P>0.05).
The pregnant endometrium harvested during days 10 to 11 and 15 to 16 was a more than
twofold higher source of A4 than the tissue collected on corresponding days of
the estrous cycle (P<0.05). The pregnant myometrium obtained on days 15 to 16 released
more A4 than that harvested during the estrous cycle (P<0.05).
Fig. 6.
Androstenedione release in vitro by endometrial and myometrial
slices harvested from pigs during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
(n=4 in each each period) and the estrous cycle (n=4 in each period) preincubated
for 18 h and subsequently incubated for 12 h. Data are expressed as the mean ± SEM.
Different small letters (a, b) indicate statistical differences in A4
secretion from tissues within one examined period (P<0.05). Asterisks (*)
indicate statistical differences in A4 secretion from the same tissues
during corresponding days of pregnancy and the estrous cycle (* 0.01≤P≤ 0.05, ***
P≤0.001).
Androstenedione release in vitro by endometrial and myometrial
slices harvested from pigs during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
(n=4 in each each period) and the estrous cycle (n=4 in each period) preincubated
for 18 h and subsequently incubated for 12 h. Data are expressed as the mean ± SEM.
Different small letters (a, b) indicate statistical differences in A4
secretion from tissues within one examined period (P<0.05). Asterisks (*)
indicate statistical differences in A4 secretion from the same tissues
during corresponding days of pregnancy and the estrous cycle (* 0.01≤P≤ 0.05, ***
P≤0.001).
Endometrial and myometrial in vitro release of P4
Endometrial release of P4 from tissues obtained from days 10 to 11, 12 to 13
and 15 to 16 did not differ between the studied days in the pregnant and cyclic pigs.
During days 12 to 13 and 15 to 16, the gravid endometrium was a higher source of
P4 than the endometrium harvested from cyclic pigs (P<0.05) (Fig. 7). The gravid myometrium released more P4 on days 12 to 13 than the
myometrium harvested on days 10 to 11 (P<0.05) and 15 to 16 (P<0.05) of pregnancy.
Production of P4 by the pregnant myometrium was lower on days 15 to 16 than on
days 10 to 11 (P<0.05) and 12 to 13 (P<0.05). During the estrous cycle, myometrial
release of P4 consequently increased during days 10 to 11, 12 to 13 (P<0.05)
and 15 to 16 (P<0.05). The pregnant myometrium harvested on days 10 to 11 was a greater
source of P4 than that harvested on days 10 to 11 of the estrous cycle
(P<0.05).
Fig. 7.
Progesterone release in vitro by endometrial and myometrial
slices harvested from pigs during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
(n=4 in each period) and the estrous cycle (n=4 in each period). Slices were
preincubated for 18 h and subsequently incubated for 12 h. Data are expressed as the
mean ± SEM. Different small letters (a, b, c) indicate statistical differences in
P4 secretion from tissues within one examined period (P<0.05).
Asterisks (**) indicate statistical differences in P4 secretion from the
same tissues during corresponding days of pregnancy and the estrous cycle (**
0.001
Progesterone release in vitro by endometrial and myometrial
slices harvested from pigs during days 10 to 11, 12 to 13 and 15 to 16 of pregnancy
(n=4 in each period) and the estrous cycle (n=4 in each period). Slices were
preincubated for 18 h and subsequently incubated for 12 h. Data are expressed as the
mean ± SEM. Different small letters (a, b, c) indicate statistical differences in
P4 secretion from tissues within one examined period (P<0.05).
Asterisks (**) indicate statistical differences in P4 secretion from the
same tissues during corresponding days of pregnancy and the estrous cycle (**
0.001
Comparison of endometrial and myometrial A4 and P4
release
Endometrial A4 release did not differ from myometrial A4 release
during any of the examined days of pregnancy and the estrous cycle (P>0.05). During
days 10 to 11 and 15 to 16 of pregnancy, the endometrium released significantly higher
amounts of P4 than the myometrium (P<0.05). In the course of the estrous
cycle, the myometrial P4 production was greater than the endometrial
P4 production on days 12 to 13 and 15 to 16 (P<0.05) (Table 2).
Table 2.
The comparison of endometrial and myometrial P4 release
M
M
M
Days 10 to 11
Days 12 to 13
Days 15 to 16
Pregnancy
E
E > M
-
-
Days 10 to 11
E
-
E = M
-
Days 12 to 13
E
-
-
E > M
Days 15 to 16
Estrous cycle
E
E = M
-
-
Days 10 to 11
E
-
E < M
-
Days 12 to 13
E
-
-
E < M
Days 15 to 16
E – endometrial P4 release, M – myometrial P4 release.
E – endometrial P4 release, M – myometrial P4 release.
Discussion
In the present study, we showed, for the first time to our knowledge, the expression of
HSD3B1 mRNA and the localization and activity of 3β-HSD protein in the
porcine uterus and in vitro production of A4 and P4
by uterine tissues harvested from pigs during days 10 to 11, 12 to 13 and 15 to 16 of
pregnancy and the estrous cycle. We documented that the activity of 3β-HSDs, both converting
DHEA into A4 and PREG into P4, differs in the endometrium and the
myometrium during the examined periods of pregnancy and the estrous cycle. We found that
endometrial and myometrial production of A4 was the highest on days 12 to 13 of
pregnancy and the estrous cycle. Endometrial versus myometrial release of A4 did
not differ. Endometrial release of P4 during the studied days of early pregnancy
and the estrous cycle did not differ. The gravid myometrium was the highest source of
P4 on days 12 to 13 of pregnancy, and the production of P4 by the
myometrium of cyclic pigs increased over the course of the studied days of the estrous
cycle. The endometrium released higher amounts of P4 on days 10 to 11 and 15 to
16 of pregnancy and lower amounts of P4 on days 12 to 13 and 15 to 16 of the
estrous cycle than the myometrium.Here we demonstrated the expression of a 3β-HSD-encoding gene in the porcine uterine
tissues. The HSD3B1 transcript abundance in the endometrium and myometrium
remained at the same level during the examined days of pregnancy. The changes in
HSD3B1 gene expression levels during the estrous cycle were much more
variable than during pregnancy. Interestingly, after luteolysis, both endometrial and
myometrial HSD3B1expression wane. Thus, we documented for the first time
that the temporal pattern of HSD3B1 gene expression depends on reproductive
status of the gilt. Past studies have determined uterine 3β-HSD-encoding gene expression in
the rodent [21] and human [22] endometrium.Our findings showed that the uterus is a steroidogenic organ in which A4 can be
synthesized from DHEA and P4 can be synthesized from PREG. We documented that
A4 and P4 synthesis in the uterus is catalyzed by active 3β-HSDs
enzymes. The presence and variable activity of 3β-HSDs was found in main populations of
uterine cells type, i.e., stromal cells, glandular, luminal and endothelial cells and
myocytes. We found that the endometrial and myometrial cell-specific localization of 3β-HSD
is similar, but that the activity of 3β-HSD in the uterus changed during the course of
pregnancy and the estrous cycle. Tissue- and developmentally specific expression of 3β-HSD
was previously found in the human and mouse placenta, skin, breast tissue, adrenal gland,
ovary and testis [for review, see 9]. The above
notions again support our idea concerning the local de novo production of
steroids in the porcine uterus, which is conditioned by specific steroidogenic enzymes
[6,7,8].The endometrium and myometrium harvested on days 12 to 13 of both pregnancy and the estrous
cycle are high sources of A4. In pregnant pigs, the endometrial and myometrial
activity of 3β-HSDs, conversion of DHEA into A4, was increased between days 10 to
13 of pregnancy. Moreover, the gravid endometrium harvested during days 10 to 11 and 15 to
16 was a more than twofold higher source of A4 than the tissue collected on
corresponding days of the estrous cycle. The pregnant myometrium obtained on days 15 to 16
released more A4 than harvested during the estrous cycle. Endometrial
A4 release during all examined days of pregnancy and the estrous cycle did not
differ from the myometrial A4 release. These results suggest that both uterine
tissues in pregnant pigs possess a huge potential for A4 production, especially
during the critical time of maternal recognition of pregnancy, i.e., days 12 to 13.Because A4 is converted to estrone (E1) by cytochrome P450 aromatase
[23] and high levels of estrogens are present in
uterine fluid around day 12 of pregnancy [14], we
have proposed that uterine-derived A4 in pigs may serve as a substrate for
estrogen production mainly around day 12 of pregnancy. At this time of pregnancy, estrogens
play a pivotal role in sustaining CL function mainly by increasing PGE2 to
PGF2α [24]. In a previous study, we
showed that higher amounts of A4 than T were released from the endometrium in
response to exogenous P4 [7]. On the other
hand, the A4 secretion pattern in the uterine tissues of cyclic pigs may suggest
an important role of A4 mainly on days 12 to 13, e.g., during the mid-luteal
phase. Thus, the porcine uterus on days 12 to 13 of both pregnancy and the estrous cycle
serve as an important source of A4. We suggest that uterine A4
produced during days 12 to 14 of the estrous cycle may act as a substrate for estrogen
synthesis in the uterus. We propose that high production of E1 in the uterus,
previously determined on days 14 to 16 in cyclic pigs [7], may be the result of A4 conversion in the uterus.In pigs, A4 was found to be the principal circulating androgen [12]. Our results showed that the porcine pregnant uterus
on days 15 to 16 is a higher source of A4 than the uterus of cyclic pigs. Thus,
we confirmed our hypothesis that porcine uterine tissues produce A4 mainly after
maternal recognition of pregnancy, e.g., on days 15 to 16. A previous study documented that
the Δ5 pathways from pregnenolone to dehydroepiandrosterone and from
androstenedione to estrogens are preferred in porcine embryos [25]. We suppose that a similar phenomenon may occur in the porcine
endometrium and myometrium.The results in vivo obtained by Stefanczyk-Krzymowska et
al. [26] demonstrated a twofold decrease
in the A4 concentration in the uterine artery in pigs after day 12 of pregnancy.
Because in our study we also observed decreased release of uterine A4 after days
12 to 13 of pregnancy, we suggest that part of A4, estimated by
Stefanczyk-Krzymowska et al. [26],
could be of uterine origin. Moreover, we observed that the A4 concentration in
culture medium obtained after 12 h of incubation of the pregnant endometrium was about
twofold higher when compared with the concentration measured after 6 h of incubation (data
not shown). This is evidence that supports our idea concerning active production of
A4 in uterine tissues.In the present study, the release of endometrial P4 did not differ during any
examined periods of pregnancy and the estrous cycle. However, the endometrium was a higher
source of P4 on days 12 to 13 and 15 to 16 of pregnancy in comparison with
corresponding days of the estrous cycle. The gravid myometrium released more P4
on days 12 to 13 of pregnancy than during days 10 to 11 and 15 to 16. It was documented that
days 12 to 13 are important for maternal recognition of pregnancy in gravid pigs and should
be accompanied by a high level of P4 in uterine fluid [3]. In cyclic pigs, myometrial P4 production increased from
days 10 to 11 through to days 15 to 16 of the estrous cycle. In our opinion, this is an
intriguing observation that may indicate: 1) more dynamic changes in secretory activity of
the myometrium when compared with the endometrium and 2) a more variable pattern of
myometrial P4 release than endometrial P4 release in
vitro.We found, for the first time, that the pregnant endometrium releases higher amounts of
P4 than the pregnant myometrium before and after maternal recognition of
pregnancy, e.g., on days 10 to 11 and 15 to 16. In cyclic pigs, the myometrium was found to
be a higher source of P4 than the endometrium on days 12 to 13 and 15 to 16 of
the estrous cycle. We showed that the endometrium is a higher source of uterine
P4 than the myometrium on days 10 to 11 and 15 to 16 of pregnancy. In cyclic
pigs on days 12 to 13 and 15 to 16, the myometrium possesses a dominant role in uterine
P4 production. Therefore, a different contribution of the endometrium and
myometrium in P4 production was demonstrated.According to Stefanczyk-Krzymowska et al. [26], no significant decrease was observed in vivo in the
P4 concentration in uterine arteries close to the ovary as well as close to the
cervix during the course of pregnancy from day 12 until day 35. Interestingly, these authors
found that the concentrations of P4 in the uterine artery determined close to the
ovary (36.7 ± 1.3 ng/ml) and close to the cervix (31.9 ± 1.0 ng/ml) were significantly
higher than the concentration of P4 in peripheral blood measured in the jugular
vein (28.4 ± 0.7 ng/ml) in pigs on day 12 of pregnancy. In our study, the higher in
vitro endometrial production of P4 in pregnant pigs than in cyclic on
days 12 to 13 suggests that the P4 determined in uterine arteries by
Stefanczyk-Krzymowska et al. may be derived not only from the ovaries but
also from the uterine tissues. Future study should determine if uterine production of
P4 depends on the part of the uterine horn.Based on the current study, we estimated that the total release of P4in
vitro within 12 h from both uterine tissues was 2000 pg per gram of uterus at
around day 12 of pregnancy. If the endometrium and myometrium together are approximately 600
g [27], about 1.2 µg of P4 will be
produced by the uterus in vitro per 12 h, and about 2.4 µg will be produced
daily. Thus, our results demonstrated that the porcine endometrium and myometrium are
significant sources of P4 during early pregnancy in pigs. We propose that the
local production of P4 is important for successful embryo-maternal cross-talk and
maintenance of pregnancy.Considering the role of uterine P4, it cannot be excluded that P4 of
myometrial origin plays an important role acting on prostaglandin F2α
(PGF2α) production by the uterus around the time of luteolysis. In cyclic pigs,
luteolysis occurs around day 15 of the estrous cycle and is caused by PGF2α of
endometrial [28] and myometrial [29] origin. It was found previously that the production
and release of PGF2α into uterine blood vessels during the estrous cycle is
triggered by about eleven days of stimulation of the endometrium by P4 [3]. Uterine P4 acting locally may support the
action of ovarian P4 in the uterus by increasing its secretory activity and
promoting angiogenesis [30, 31]. It was found that P4 blocks myometrial
oxytocin-stimulated prostaglandin (PGs) secretion in pregnant pigs and serves as a factor of
the mechanism of corpus luteum protection during pregnancy [32]. Moreover, during early pregnancy, P4 may inhibit the effect of
oxytocin on intracellular Ca2+ release [24] and may decrease oxytocin receptor expression [33, 34] and cyclooxygenase-2 activity
[35].In summary, the current study revealed that 1) 3β-HSD mRNA and protein are present and
active in the porcine endometrium and myometrium; 2) uterine tissues produce A4
and P4 during both early pregnancy and the estrous cycle and steroid secretion
in vitro differs over the course of early pregnancy and the estrous
cycle; 3) both porcine uterine tissues release high amounts of A4 during days 12
to 13 of pregnancy and the estrous cycle; 4) production of A4 did not differ
between the endometrium and myometrium; 5) the endometrial P4 production rate is
stable over the course of early pregnancy and the estrous cycle; 6) the endometrium from day
12 of pregnancy produces more P4 than that harvested during corresponding days of
the estrous cycle; 7) myometrial production of P4 increases during days 10 to 16
of the estrous cycle; and 8) endometrial production of P4 in gravid pigs is
higher than the myometrial production on days 10 to 11 and 15 to 16 of pregnancy, while that
in cyclic pigs is lower between days 12 to 13 and 15 to 16. In conclusion, porcine uterine
tissues express active 3β-HSD and therefore possess an ability to synthesize and release
A4 and P4, which are important for regulation of early pregnancy and
the estrous cycle.
Authors: Hee Sub Rhee; Seon Hee Oh; Bum Joo Ko; Dong Min Han; Byung Hun Jeon; Hyun Park; Hyung Bae Moon; Won Sin Kim Journal: Exp Mol Med Date: 2003-06-30 Impact factor: 8.718
Authors: Joonho Moon; Ji-Yei Choi; Jung-Taek Kang; Sol Ji Park; Su Jin Kim; Goo Jang; Byeong Chun Lee Journal: J Vet Sci Date: 2013-12-27 Impact factor: 1.672